Lipoprotein levels in newborns and adolescents.
Previous studies established that cardiovascular disease can be predicted early in life. Active modification of risk factors in the general population should include screening as the first step. For this reason, lipoproteins and apolipoproteins were measured in newborns and adolescents. Almost all lipids and apolipoproteins were much lower at birth than at adolescence. Based on these results, reference ranges were calculated.
Gozlan
O
O
Department of Biochemistry, Carmel Hospital, Haifa, Israel.
Gross
D
D
Gruener
N
N
D000293:Adolescent; D000375:Aging / Q000097:blood; D001053:Apolipoproteins / Q000097:blood*; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D006801:Humans; D007231:Infant, Newborn; D007557:Israel / Q000453:epidemiology; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D015997:Neonatal Screening; D012016:Reference Values; D012307:Risk Factors
D001053:Apolipoproteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008074:Lipoproteins